Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medinotec (MDNC) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for Medinotec (MDNC) over the last 4 years, with Q4 2025 value amounting to $403411.0.

  • Medinotec's Net Income towards Common Stockholders fell 3906.65% to $403411.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $4.5 million, marking a year-over-year increase of 21014.2%. This contributed to the annual value of $3.9 million for FY2025, which is 388096.97% up from last year.
  • According to the latest figures from Q4 2025, Medinotec's Net Income towards Common Stockholders is $403411.0, which was down 3906.65% from $342880.0 recorded in Q3 2025.
  • Medinotec's Net Income towards Common Stockholders' 5-year high stood at $3.2 million during Q1 2025, with a 5-year trough of -$492371.0 in Q4 2023.
  • Moreover, its 4-year median value for Net Income towards Common Stockholders was $52777.0 (2023), whereas its average is $305557.4.
  • As far as peak fluctuations go, Medinotec's Net Income towards Common Stockholders plummeted by 283409.81% in 2023, and later soared by 76845.62% in 2024.
  • Medinotec's Net Income towards Common Stockholders (Quarter) stood at -$16781.0 in 2022, then crashed by 2834.1% to -$492371.0 in 2023, then soared by 234.46% to $662051.0 in 2024, then plummeted by 39.07% to $403411.0 in 2025.
  • Its Net Income towards Common Stockholders stands at $403411.0 for Q4 2025, versus $342880.0 for Q3 2025 and $525618.0 for Q2 2025.